ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2021

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2021

ResMed (RMD) Tops Q4 EPS by 7c

August 5, 2021 4:09 PM EDT

ResMed (NYSE: RMD) reported Q4 EPS of $1.35, $0.07 better than the analyst estimate of $1.28. Revenue for the quarter came in at $876.1 million versus the consensus estimate of $783.18 million.

Our fourth quarter and full-year fiscal year 2021 results continue to demonstrate the strength and resiliency of our business, said Mick Farrell, ResMeds CEO. During the quarter, we saw the ongoing recovery of core sleep apnea and COPD patient flow across... More